Please provide your email address to receive an email when new articles are posted on . Risk for mortality, stroke and permanent pacemaker implantation after transcatheter aortic valve replacement ...

With more self-contained models potentially on their way to patients, the FDA is taking steps to remind healthcare providers of certain risks posed by leadless pacemakers, including the possibility of ...

The US Food and Drug Administration (FDA) is reminding healthcare providers about the risk of major complications if cardiac perforation occurs during leadless pacemaker implantation. Cardiac ...

Around one in every nine patients who undergo TAVI with a new-generation self-expanding device will need permanent pacemaker implantation (PPI) within the next 30 days, according to an analysis of ...

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods: ...

Among Medicare beneficiaries, implantation was especially frequent for female patients and those undergoing tricuspid valve replacement with or without concomitant left-sided heart surgeries.

MIAMI, FL—Rates of permanent pacemaker implantation within 30 days of TAVI have come down over time in the United States, although there remains a need for further improvements, data from the Society ...

Please provide your email address to receive an email when new articles are posted on . In an advisory letter, the FDA reminded clinicians of the risk for major complications should cardiac ...

Needing a permanent pacemaker after surgical aortic valve replacement (SAVR) was linked to mortality in Swedish registry data. Such risk was not apparent in the first few years: all-cause mortality ...